A | ||||
---|---|---|---|---|
Outcome variable (Reduced access to diabetes medicine) response category | P-value | |||
Exposure variable | Exposure variable category | Yes | No/not sure | |
Age group | < 50 years | 35 (17.2%) | 168 (82.8%) | 0.99 |
50 years or above | 59 (17.4%) | 281 (82.6%) | ||
Gender | Male | 48 (16.8%) | 237 (83.2%) | 0.82 |
Female | 46 (17.8%) | 212 (82.2%) | ||
Duration of diabetes | Up to 5 years | 36 (17.0%) | 176 (83.0%) | 0.91 |
> 5 years | 58 (17.5%) | 273 (82.5%) | ||
Treatment of diabetes | Non-insulin | 48 (13.4%) | 310 (86.6%) | 0.001* |
Insulin/combined | 46 (25.0%) | 138 (75.0%) | ||
Presence of diabetes complications like retinopathy | Yes | 14 (26.9%) | 38 (73.1%) | 0.08 |
No/not sure | 79 (16.2%) | 409 (83.8%) | ||
Needing to self-isolate | Yes | 28 (25.5%) | 82 (74.5%) | 0.02* |
No/prefer not say | 66 (15.2%) | 367 (84.8%) | ||
Duration of self-isolation | Up to 1 week | 8 (21.1%) | 30 (78.9%) | 0.64 |
More than 1 week | 19 (26.0%) | 54 (74.0%) |
B | ||||
---|---|---|---|---|
Exposure variable | Exposure variable category | Association with reduced access to diabetes medicine | P-value | |
Odds Ratio (95% CI) | ||||
Treatment of diabetes | Insulin or combined | 2.13 | (1.35–3.35) | 0.001* |
Non-insulin (Reference) | ||||
Needing to self-isolate | Yes | 1.86 | (1.11–3.09) | 0.02* |
No/prefer not say (Reference) |